Sabrina Khan

2PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Feb 15, 2026
Optimal Dosage Justification for Datopotamab Deruxtecan in HR-Positive/HER2-Negative Breast Cancer Through Model-Informed Drug Development Approaches.

Zoey Tang, KyoungSoo Lim, Yu Jiang

|Sep 12, 2024
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01.

Aditya Bardia, Komal Jhaveri, Seock-Ah Im

Pageof 1

Frequent Collaborators

1 joint publications

Aditya Bardia

1 joint publications

Komal Jhaveri

1 joint publications

Seock-Ah Im

1 joint publications

Sonia Pernas